NuVasive shares decreased by 1.1 percent this past week and dropped 6.44 percent in the last four weeks, according to the American Trade Journal.
Here are five quick facts:
1. NuVasive has underperformed the index by 5.65 percent in the last four weeks.
2. The shares presently have a recommended consensus of "buy."
3. The shares registered a one year high of $51.25 on May 29, 2015. On July 18, 2014, the shares had a one-year low of $32.39.
4. The 50-day moving average is $48.8 and the 200-day moving average is $46.67.
5. On Friday, the shares opened for trading at $46.64 and hit $46.96. The shares ended the session at $46.77.
More articles on devices:
Medtronic gives $1.1M in health access grants for underserved communities — 5 key notes
5 key thoughts on K2M: Is an acquisition in the future?
America responds to FDA questions on spinal device: 5 key notes